Six regions. One plant. Regulatory approvals held at the source.

Naprod's oncology, anesthesia, and critical-care injectables reach Latin America through direct plant-level regulatory approvals rather than distributor-only registrations. The Tarapur facility holds ANVISA (Brazil) and INVIMA (Colombia) clearances, with ANVISA renewing the plant's GMP certification in January 2026 — reported by Pharma India Magazine. Company search-console data also records demand signals from Peru.

• ANVISA , Brazil Verified

  Agência Nacional de Vigilância Sanitária (ANVISA)

• INVIMA , Colombia Verified

  Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)

• DIGEMID , Peru Being digitized

  Dirección General de Medicamentos, Insumos y Drogas (DIGEMID)

  IT-team draft list spells this 'DIGIMED'; likely refers to DIGEMID (Perú). Unverified — company must confirm before publishing.

Counts pending Country-level registration counts pending confirmation. Brazil and Colombia are held as direct plant-level regulatory approvals (ANVISA, INVIMA); Peru is tracked via an internal draft register awaiting company sign-off before publication as verified.

Across Sub-Saharan and North Africa, Naprod's WHO-GMP certification anchors entry into regulatory frameworks that reference WHO-GMP-listed manufacturers. A wider slate of national regulator relationships — spanning Nigeria, Ethiopia, Tanzania, Kenya, Zimbabwe, Zambia, Côte d'Ivoire, Uganda, and Ghana — is on record internally and is being digitized for public verification.

• WHO-GMP Verified

  World Health Organization — Good Manufacturing Practice

• NAFDAC , Nigeria Being digitized

  National Agency for Food and Drug Administration and Control

• FMHACA , Ethiopia Being digitized

  Food, Medicine and Healthcare Administration and Control Authority

• TFDA , Tanzania Being digitized

  Tanzania Food and Drugs Authority

• PPB , Kenya Being digitized

  Pharmacy and Poisons Board

• MCAZ , Zimbabwe Being digitized

  Medicines Control Authority of Zimbabwe

• PRA , Zambia Being digitized

  Zambia Medicines Regulatory Authority (formerly Pharmaceutical Regulatory Authority)

• DPM , Côte d'Ivoire Being digitized

  Direction de la Pharmacie et du Médicament

• NDA , Uganda Being digitized

  National Drug Authority

• FDB , Ghana Being digitized

  Food and Drugs Authority (draft list: FDB)

Counts pending Country-level registration counts pending confirmation; the national-agency list above is drawn from an internal draft register awaiting company sign-off before individual country approvals are published as verified. WHO-GMP is independently confirmed and serves as a baseline credential across the region.

Gulf-region supply is anchored by direct regulatory approvals from the UAE Ministry of Health and Prevention and Bahrain's National Health Regulatory Authority. Company search-console data records the United Arab Emirates among the highest-demand markets outside currently served regions, with additional search interest recorded from Yemen.

• UAE Ministry of Health , United Arab Emirates Verified

  UAE Ministry of Health and Prevention (MOHAP)

• NHRA Bahrain , Bahrain Verified

  National Health Regulatory Authority

Counts pending Country-level registration counts pending confirmation. UAE and Bahrain hold direct plant-level regulatory approvals; Yemen is tracked as a search-demand signal only, with no registration on record.

Naprod's WHO-GMP standing supports registration pathways across Southeast Asian markets that recognize WHO-GMP or PIC/S-aligned authorities, including Indonesia's BPOM and Malaysia's NPRA — a PIC/S member agency. Company search-console data records demand signals from Vietnam, Thailand, and Malaysia.

• WHO-GMP Verified

  World Health Organization — Good Manufacturing Practice

• BPOM , Indonesia Being digitized

  Badan Pengawas Obat dan Makanan

• NPRA (PIC/S) , Malaysia Being digitized

  National Pharmaceutical Regulatory Agency — PIC/S member

Counts pending Country-level registration counts pending confirmation; Indonesia and Malaysia approvals are drawn from an internal draft register awaiting company sign-off before publication as verified. WHO-GMP is independently confirmed and serves as a baseline credential across the region.

Naprod's WHO-GMP certification underpins registration filings across CIS markets that reference WHO-listed manufacturers, with a national-level approval on record from Ukraine's state medicines authority. Company search-console data records demand signals from Ukraine, extending into neighboring Turkey.

• WHO-GMP Verified

  World Health Organization — Good Manufacturing Practice

• SAUMP , Ukraine Being digitized

  State Administration of Ukraine on Medicinal Products

Counts pending Country-level registration counts pending confirmation; the Ukraine approval is drawn from an internal draft register awaiting company sign-off before publication as verified. Turkey is tracked as a search-demand signal only, with no registration on record. Wider CIS coverage beyond Ukraine is not yet documented.

Regional coverage rests on Naprod's WHO-GMP certification, which typically anchors entry into South Asian regulatory frameworks that reference WHO-listed manufacturers. Company search-console data records notable search demand from Pakistan; formal country-level registrations across the region are not yet documented.

• WHO-GMP Verified

  World Health Organization — Good Manufacturing Practice

Counts pending Country-level registration counts pending confirmation for all listed markets; WHO-GMP is independently confirmed and typically anchors entry into regulatory frameworks across the region. Pakistan shows recorded search-demand in company search-console data; no country-specific registration is currently on record for any market in this region.